The thoracic drainage devices market has seen considerable growth due to a variety of factors.
• In recent times, the thoracic drainage devices market has shown robust growth. The market will expand from its size of $0.89 billion in 2024 to reach $0.97 billion in 2025, marking a compound annual growth rate (CAGR) of 8.95%.
Factors driving the growth during the historic period include an uptick in pulmonary diseases, increased occurrences of thoracic surgeries, a growing older population, wider acceptance of minimally invasive methods, and a rise in cases of pneumothorax and pleural effusion.
The thoracic drainage devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for thoracic drainage devices is poised for robust expansion in the forthcoming years, with projections indicating a growth to $1.35 billion by 2029, progressing at a compound annual growth rate (CAGR) of 8.58%.
The predicted growth throughout this period can be ascribed to factors such as increased healthcare spending, heightened awareness of post-operative care, improvements in global hospital facilities, the escalating demand for transportable drainage systems, and widened usage of disposable medical equipment. Key trends anticipated during this period include medical device technological advancements, enhancements in chest drainage systems, the advent of smart monitoring systems, novelty in catheter and tubing materials, and the implementation of antimicrobial coatings in drainage devices.
The rise in cardiovascular and pulmonary disorders is anticipated to drive the growth of the thoracic drainage devices market. These disorders impact the heart, blood vessels, and lungs, affecting cardiovascular and respiratory health. They are being increasingly caused by sedentary lifestyles, poor diets, smoking, and a lack of routine health checks. The demand for specific treatment options and preventive measures is increasing as a result of this increase. Thoracic drainage devices play a critical part in managing such conditions by efficiently eliminating excessive fluid, air, or blood from the pleural or thoracic cavity, therefore securing optimal lung expansion and cardiovascular function. The Australian Institute of Health and Welfare reported that doctor-certified fatalities from coronary heart disease (CHD) climbed to 14,100 in 2021 and even more to 14,900 in 2022. Further, in 2022, COPD was responsible for 7,691 deaths or 29.6 deaths per 100,000 population, contributing to 4.0% of all fatalities. Therefore, the rising prevalence of cardiovascular and pulmonary disorders is boosting the growth of the thoracic drainage devices market. There is a growing predilection for minimally invasive surgeries which is also propelling the thoracic drainage devices market. Such surgeries involve minor or no incisions, use advanced instruments and cameras, resulting in reduced tissue damage, quicker recovery, and lesser scarring than traditional open surgery. These benefits have led to a growing preference for these procedures. Thoracic drainage devices are critical in these surgeries as they effectively manage pleural effusions, air leaks, and fluid accumulation, ensuring lung expansion and cutting down the risk of complications during recovery. According to the American Society of Plastic Surgeons, minimally invasive procedures saw a 7 percent increase in 2023, outpacing the growth rate of surgical procedures by 2 percent. Thus, the growing preference for these surgeries adds to the increasing demand in the thoracic drainage devices market.
The thoracic drainage devices market covered in this report is segmented –
1) By Type: Digital, Traditional
2) By Product: Thoracic Drainage Systems, Thoracic Drainage Kits, Pleural Drainage Catheters, Other Products
3) By Application: Cardiac Surgery, Thoracic And Pulmonary Surgery, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Digital: Electronic Monitoring Systems, Digital Drainage Units With Real-Time Pressure Measurement, Automated Fluid Monitoring Devices
2) By Traditional: Suction Drainage Systems, Gravity Drainage Systems, Water-Seal Chest Drains
Key corporations in the thoracic drainage devices market are prioritizing the launch of advanced products, such as evacuated drainage bottles, to escalate productivity and minimize infection risks during medical practices. These evacuated drainage bottles are employed to collect and stow fluid extracted from wounds or surgical sites, typically under vacuum pressure, to aid healing and prevent infection. For instance, Merit Medical Systems Inc., a U.S.-based disposable medical devices producer, released the Aspira evacuated drainage bottle in September 2023. It's specially designed for expulsion of pleural effusions and malignant ascites, thus providing patients with the opportunity for home-based self-care with elevated comfort and the ability to manage drainage velocity. Moreover, it requires 23% less storage footprint than conventional drainage bottles.
Major companies operating in the thoracic drainage devices market are include:
• Medtronic plc
• Terumo Corporation
• Smiths Group plc
• Teleflex Incorporated
• Cook Group Incorporated
• Merit Medical Systems
• Vygon SA
• Poly Medicure Ltd.
• B. Braun Melsungen AG
• Medela AG
• Utah Medical Products Inc.
• Angiplast Private Limited
• Sterimed Medical Devices Private Limited
• Eurosets s.r.l.
• Redax S.p.a.
• Sinapi Biomedical (Pty) Ltd.
• Rocket Medical plc
• ATMOS MedizinTechnik GmbH & Co. KG
• Argon Medical Devices Inc.
• Sterimed Medical Devices Pvt. Ltd.
North America was the largest region in the thoracic drainage devices market in 2024. The regions covered in the thoracic drainage devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.